No Result
View All Result
Wednesday, November 18, 2026
MM News
اردو
  • Home
  • Latest News
  • National
  • Crime
  • Opinions
  • The Other Side
MM News
  • Home
  • Latest News
  • National
  • Crime
  • Opinions
  • The Other Side
No Result
View All Result
No Result
View All Result
MM News
اردو
  • Latest
  • National
  • Crime
  • Opinions
  • The Other Side-Pakistan
Home Uncategorized

Sinopharm’s COVID-19 vaccine 72.8% effective in latest study

MM News Staff by MM News Staff
May 27, 2021
Reading Time: 1 min read
China’s Sinopharm Publishes Awaited Covid Vaccine Study Details. Source: Bloomberg

China’s Sinopharm Publishes Awaited Covid Vaccine Study Details. Source: Bloomberg

BEIJING: Two COVID-19 vaccines from China’s Sinopharm showed more than 70% efficacy against symptomatic cases, according to the first detailed result of a large late-stage study published to the public.

A vaccine developed by a Wuhan-based subsidiary of Sinopharm was 72.8% effective against symptomatic COVID-19 at least two weeks after second injection, based on interim results, the peer-reviewed study published in the Journal of the American Medical Association showed.

This is slightly better than the 72.5% rate announced in a company statement in February. It remains unclear how much protection they provide against severe or asymptomatic cases

ADVERTISEMENT

Another vaccine developed by a Beijing-based institute linked to Sinopharm, which this month obtained emergency use approval by the World Health Organization (WHO), showed a 78.1% efficacy, the paper said.

The readings were based on calculations over 142 symptomatic cases in a trial involving more than 40,000 participants, with 26 injected with the Wuhan unit’s vaccine and 21 with the Beijing unit’s shot, it said.

“There were only 2 severe cases of COVID-19 among participants, so conclusions about prevention of severe cases cannot be made,” the paper said.

“The study could not address the question of whether the… vaccines prevent against asymptomatic infection, which requires formal study-wide surveillance via virologic and serologic tests,” it said.

The trial, conducted in countries including the United Arab Emirates and Bahrain, did not recruit pregnant women and people under 18, while data was insufficient for the elderly and those with chronic diseases, researchers said. Data from other trial sites in Egypt and Jordan will be included in the final analysis

Tags: covid 19sinopharmvaccine
ShareTweetSendShare
Previous Post

‘Friends: The Reunion’: Jennifer Aniston and David Schwimmer admit having mutual crush

Next Post

We only realize about coronavirus when we lose a loved one: Bushra Ansari

Related Stories

Uncategorized

Emergency at Tarbela Hydropower Project as Water Enters Tunnel Construction Area

November 9, 2026
Photo, online
Uncategorized

Riyadh Air Suspends Flights from Riyadh Until November 7, Operations Shift to Qassim

October 25, 2026
File photo
Uncategorized

Tiger Shroff Case: Suspects Surveyed Salman & Amitabh’s Homes

October 22, 2026
File
Uncategorized

Petrol at Rs387, Diesel at Rs397 per Litre! When Will the Shehbaz Government Give Relief to the Public?

October 17, 2026
Next Post

We only realize about coronavirus when we lose a loved one: Bushra Ansari

Latest

Bilawal Questions Pakistan’s System, But Who Will Question PPP’s 18-Year Rule in Sindh?

5 hours ago

Pakistani National or Iranian Agent? Man Behind Alleged Trump Assassination Plot Gets 27 Years

6 hours ago

Pakistani Group Acquires US Consul General’s Residence in Karachi for Rs6.92 Billion

7 hours ago

Gold Prices Crash to Lowest Level Since Sep 2025; Silver and Platinum Also Slide

7 hours ago

Middle East Tensions Fail to Stop Oil Price Decline as Brent Slips to $92.98

7 hours ago

Pakistan Forex Rates Today: Dollar, Pound, Euro and Riyal Prices Revealed

8 hours ago

Will Your Area Face a Power Cut on November 18? K-Electric Releases New Schedule

1 day ago

Bilawal Bhutto Drops a Political Bombshell, Says Pakistan Needs a Major Reset

1 day ago

Latest

Bilawal Questions Pakistan’s System, But Who Will Question PPP’s 18-Year Rule in Sindh?

5 hours ago

Pakistani National or Iranian Agent? Man Behind Alleged Trump Assassination Plot Gets 27 Years

6 hours ago

Pakistani Group Acquires US Consul General’s Residence in Karachi for Rs6.92 Billion

7 hours ago

Gold Prices Crash to Lowest Level Since Sep 2025; Silver and Platinum Also Slide

7 hours ago

Middle East Tensions Fail to Stop Oil Price Decline as Brent Slips to $92.98

7 hours ago

Pakistan Forex Rates Today: Dollar, Pound, Euro and Riyal Prices Revealed

8 hours ago

MM Digital (Pvt.) Ltd.

MM News is a subsidiary of the MM Group of Companies. It was established in 2019 with the aim of providing people of Pakistan access to unbiased information. Contact Details: 03200201537

Quick Links

  • Home
  • Advertise
  • MM News Urdu
  • The Other Side-Pakistan
  • Contact Us
  • Privacy Policy

Top Pages

  • Latest News
  • Showbiz
  • OP-ED
  • Technology
No Result
View All Result
  • Latest News
  • National
  • Crime
  • Opinions

© Copyright 2024 MMNews - All Rights Reserved.